# Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis

> **NCT05331222** · NA · TERMINATED · sponsor: **Jantar GmbH** · enrollment: 3 (actual)

## Conditions studied

- Chronic Rhinitis
- Chronic Sinus Congestion

## Interventions

- **DRUG:** JT-1

## Key facts

- **NCT ID:** NCT05331222
- **Lead sponsor:** Jantar GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-09-30
- **Primary completion:** 2023-03-03
- **Final completion:** 2023-03-03
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** regulatory issues
- **Last updated:** 2023-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05331222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05331222, "Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05331222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*